400 related articles for article (PubMed ID: 17197178)
1. Novel pyridinyl and pyrimidinylcarbazole sulfonamides as antiproliferative agents.
Hu L; Li ZR; Wang YM; Wu Y; Jiang JD; Boykin DW
Bioorg Med Chem Lett; 2007 Mar; 17(5):1193-6. PubMed ID: 17197178
[TBL] [Abstract][Full Text] [Related]
2. Novel potent antimitotic heterocyclic ketones: synthesis, antiproliferative activity, and structure-activity relationships.
Hu L; Jiang JD; Qu J; Li Y; Jin J; Li ZR; Boykin DW
Bioorg Med Chem Lett; 2007 Jul; 17(13):3613-7. PubMed ID: 17482458
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of carbazole sulfonamides as a novel class of antimitotic agents against solid tumors.
Hu L; Li ZR; Li Y; Qu J; Ling YH; Jiang JD; Boykin DW
J Med Chem; 2006 Oct; 49(21):6273-82. PubMed ID: 17034133
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
[TBL] [Abstract][Full Text] [Related]
5. N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer.
Wang YM; Hu LX; Liu ZM; You XF; Zhang SH; Qu JR; Li ZR; Li Y; Kong WJ; He HW; Shao RG; Zhang LR; Peng ZG; Boykin DW; Jiang JD
Clin Cancer Res; 2008 Oct; 14(19):6218-27. PubMed ID: 18829501
[TBL] [Abstract][Full Text] [Related]
6. In vitro antitumor activity of N-glycosyl sulfonamides.
Crespo R; de Bravo MG; Colinas PA; Bravo RD
Bioorg Med Chem Lett; 2010 Nov; 20(22):6469-71. PubMed ID: 20888767
[TBL] [Abstract][Full Text] [Related]
7. Novel benzopyridothiadiazepines as potential active antitumor agents.
Lebegue N; Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Chavatte P; Berthelot P
J Med Chem; 2005 Nov; 48(23):7363-73. PubMed ID: 16279796
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activity of novel tetralin-6-ylpyridine and tetralin-6-ylpyrimidine derivatives.
Amin KM; El-Zahar MI; Anwar MM; Kamel MM; Mohamed MH
Acta Pol Pharm; 2009; 66(3):279-91. PubMed ID: 19645328
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin.
Guianvarc'h D; Duca M; Boukarim C; Kraus-Berthier L; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C; Dauzonne D
J Med Chem; 2004 Apr; 47(9):2365-74. PubMed ID: 15084135
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives.
Sławiński J; Brzozowski Z
Eur J Med Chem; 2006 Oct; 41(10):1180-9. PubMed ID: 16777268
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
Rostom SA
Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of substituted triazolo[4,3-a]pyrimidin-6-sulfonamide with an incorporated thiazolidinone moiety.
Hafez HN; El-Gazzar AR
Bioorg Med Chem Lett; 2009 Aug; 19(15):4143-7. PubMed ID: 19540114
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antiproliferative activities and in vitro biological evaluation of novel benzofuransulfonamide derivatives.
Yang L; Lei H; Mi CG; Liu H; Zhou T; Zhao YL; Lai XY; Li ZC; Song H; Huang WC
Bioorg Med Chem Lett; 2011 Sep; 21(18):5389-92. PubMed ID: 21795045
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
Al-Said MS; Ghorab MM; Al-Qasoumi SI; El-Hossary EM; Noaman E
Eur J Med Chem; 2010 Jul; 45(7):3011-8. PubMed ID: 20413187
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agents.
Chen J; Liu T; Wu R; Lou J; Cao J; Dong X; Yang B; He Q; Hu Y
Bioorg Med Chem; 2010 Dec; 18(24):8478-84. PubMed ID: 21067933
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
Ghorab MM; Ragab FA; Hamed MM
Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, molecular structure, and in vitro antitumor activity of new 4-chloro-2-mercaptobenzenesulfonamide derivatives.
Sławiński J; Gdaniec M
Eur J Med Chem; 2005 Apr; 40(4):377-89. PubMed ID: 15804537
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, anti-HIV-1 integrase, and cytotoxic activities of 4-chloro-N-(4-oxopyrimidin-2-yl)-2-mercaptobenzenesulfonamide derivatives.
Brzozowski Z; Sławiński J; Saczewski F; Sanchez T; Neamati N
Eur J Med Chem; 2008 Jun; 43(6):1188-98. PubMed ID: 17949860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]